{"id":"https://openalex.org/W1996715170","doi":"https://doi.org/10.1007/s40261-013-0128-3","title":"Pharmacokinetics, Safety, and Tolerability of Saroglitazar (ZYH1), a Predominantly PPAR\u03b1 Agonist with Moderate PPAR\u03b3 Agonist Activity in Healthy Human Subjects","display_name":"Pharmacokinetics, Safety, and Tolerability of Saroglitazar (ZYH1), a Predominantly PPAR\u03b1 Agonist with Moderate PPAR\u03b3 Agonist Activity in Healthy Human Subjects","publication_year":2013,"publication_date":"2013-09-23","ids":{"openalex":"https://openalex.org/W1996715170","doi":"https://doi.org/10.1007/s40261-013-0128-3","mag":"1996715170","pmid":"https://pubmed.ncbi.nlm.nih.gov/24062180","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3824340"},"language":"en","primary_location":{"id":"doi:10.1007/s40261-013-0128-3","doi":"https://doi.org/10.1007/s40261-013-0128-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40261-013-0128-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40261-013-0128-3.pdf","source":{"id":"https://openalex.org/S138241747","display_name":"Clinical Drug Investigation","issn_l":"0114-2402","issn":["0114-2402","1173-2563","1179-1918","2196-4920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Drug Investigation","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40261-013-0128-3.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102905030","display_name":"Rajendrakumar H. Jani","orcid":"https://orcid.org/0000-0002-7077-8024","observed_orcids":["https://orcid.org/0000-0002-7077-8024"]},"institutions":[{"id":"https://openalex.org/I4210132663","display_name":"Zydus Lifesciences Limited (India)","ror":"https://ror.org/03ktyvw44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210132663"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Rajendra H. Jani","raw_affiliation_strings":["Clinical R&D, Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H. No.\u00a08A, Moriya, Ahmedabad, 382\u00a0213, Gujarat, India, rhjani@zyduscadila.com","Clinical R&D, Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical R&D, Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H. No.\u00a08A, Moriya, Ahmedabad, 382\u00a0213, Gujarat, India, rhjani@zyduscadila.com","institution_ids":["https://openalex.org/I4210132663"]},{"raw_affiliation_string":"Clinical R&D, Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, India","institution_ids":["https://openalex.org/I4210132663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075430507","display_name":"Kevinkumar Kansagra","orcid":"https://orcid.org/0000-0001-9157-498X","observed_orcids":["https://orcid.org/0000-0001-9157-498X"]},"institutions":[{"id":"https://openalex.org/I4210132663","display_name":"Zydus Lifesciences Limited (India)","ror":"https://ror.org/03ktyvw44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210132663"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Kevinkumar Kansagra","raw_affiliation_strings":["Clinical R&D, Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H. No. 8A, Moriya, Ahmedabad, 382 213, Gujarat, India","Clinical R&D, Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical R&D, Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H. No. 8A, Moriya, Ahmedabad, 382 213, Gujarat, India","institution_ids":["https://openalex.org/I4210132663"]},{"raw_affiliation_string":"Clinical R&D, Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, India","institution_ids":["https://openalex.org/I4210132663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102971102","display_name":"Mukul Rameshchandra Jain","orcid":"https://orcid.org/0000-0001-5730-1435","observed_orcids":["https://orcid.org/0000-0001-5730-1435"]},"institutions":[{"id":"https://openalex.org/I4210132663","display_name":"Zydus Lifesciences Limited (India)","ror":"https://ror.org/03ktyvw44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210132663"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Mukul R. Jain","raw_affiliation_strings":["Pharmacology & Toxicology, Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H. No. 8A, Moriya, Ahmedabad, 382 213, Gujarat, India","Pharmacology & Toxicology, Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology & Toxicology, Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H. No. 8A, Moriya, Ahmedabad, 382 213, Gujarat, India","institution_ids":["https://openalex.org/I4210132663"]},{"raw_affiliation_string":"Pharmacology & Toxicology, Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, India","institution_ids":["https://openalex.org/I4210132663"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102963245","display_name":"Harilal Patel","orcid":"https://orcid.org/0000-0003-0413-5079","observed_orcids":["https://orcid.org/0000-0003-0413-5079"]},"institutions":[{"id":"https://openalex.org/I4210132663","display_name":"Zydus Lifesciences Limited (India)","ror":"https://ror.org/03ktyvw44","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210132663"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Harilal Patel","raw_affiliation_strings":["Drug Metabolism & Pharmacokinetics, Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H. No. 8A, Moriya, Ahmedabad, 382 213, Gujarat, India","Drug Metabolism & Pharmacokinetics, Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Metabolism & Pharmacokinetics, Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H. No. 8A, Moriya, Ahmedabad, 382 213, Gujarat, India","institution_ids":["https://openalex.org/I4210132663"]},{"raw_affiliation_string":"Drug Metabolism & Pharmacokinetics, Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, India","institution_ids":["https://openalex.org/I4210132663"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5102905030"],"corresponding_institution_ids":["https://openalex.org/I4210132663"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":{"value":4190,"currency":"USD","value_usd":4190},"fwci":2.2181,"has_fulltext":true,"cited_by_count":63,"citation_normalized_percentile":{"value":0.88819015,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"33","issue":"11","first_page":"809","last_page":"816"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12975","display_name":"Paraoxonase enzyme and polymorphisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/saroglitazar","display_name":"saroglitazar","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pparalpha-agonists","display_name":"PPAR\u03b1 agonist","score":0.9710000157356262},{"id":"https://openalex.org/keywords/ppargamma-agonists","display_name":"PPAR\u03b3 agonists","score":0.9660000205039978},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.972000002861023},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7710000276565552},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8510000109672546},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9919999837875366},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.5220000147819519},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.9129999876022339},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.5389999747276306},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.546999990940094},{"id":"https://openalex.org/keywords/renal-excretion","display_name":"renal excretion","score":0.5230000019073486},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.32899999618530273}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.815346896648407},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7898695468902588},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6972113847732544},{"id":"https://openalex.org/C7341990","wikidata":"https://www.wikidata.org/wiki/Q10331450","display_name":"PPAR agonist","level":4,"score":0.5962572693824768},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5855680108070374},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5515496730804443},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4878949820995331},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.481792151927948},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46826818585395813},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.45371636748313904},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4283349812030792},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.27845239639282227},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2591937780380249},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010666","descriptor_name":"Phenylpropionates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010666","descriptor_name":"Phenylpropionates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D010666","descriptor_name":"Phenylpropionates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018565","descriptor_name":"Food-Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047493","descriptor_name":"PPAR alpha","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1007/s40261-013-0128-3","doi":"https://doi.org/10.1007/s40261-013-0128-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40261-013-0128-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40261-013-0128-3.pdf","source":{"id":"https://openalex.org/S138241747","display_name":"Clinical Drug Investigation","issn_l":"0114-2402","issn":["0114-2402","1173-2563","1179-1918","2196-4920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Drug Investigation","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2820695","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3824340","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24062180","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24062180","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical drug investigation","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:3824340","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3824340/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Drug Investig","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.777.5633","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.777.5633","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/80/ab/40261_2013_Article_128.PMC3824340.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1007/s40261-013-0128-3","doi":"https://doi.org/10.1007/s40261-013-0128-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40261-013-0128-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40261-013-0128-3.pdf","source":{"id":"https://openalex.org/S138241747","display_name":"Clinical Drug Investigation","issn_l":"0114-2402","issn":["0114-2402","1173-2563","1179-1918","2196-4920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Drug Investigation","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306089","display_name":"American Diabetes Association","ror":"https://ror.org/04f6cgz95"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1996715170.pdf","grobid_xml":"https://content.openalex.org/works/W1996715170.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1963542379","https://openalex.org/W1969853443","https://openalex.org/W2016622896","https://openalex.org/W2045426425","https://openalex.org/W2097225786","https://openalex.org/W2102108180","https://openalex.org/W2104359225","https://openalex.org/W2137116210","https://openalex.org/W2137936645","https://openalex.org/W2328529137","https://openalex.org/W2396611350","https://openalex.org/W2411329118","https://openalex.org/W2510708214"],"related_works":["https://openalex.org/W7100449831","https://openalex.org/W2761299105","https://openalex.org/W2127161077","https://openalex.org/W2054762675","https://openalex.org/W2950722971","https://openalex.org/W4230774970","https://openalex.org/W1556802048","https://openalex.org/W2162730134","https://openalex.org/W2014179730","https://openalex.org/W2965563692"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"OBJECTIVES:":[2],"Dyslipidaemia":[3],"is":[4,18],"a":[5,19,78,200,247,294,380],"major":[6],"cardiovascular":[7],"risk":[8],"factor":[9],"associated":[10],"with":[11,26,199],"type":[12,50],"2":[13,51],"diabetes":[14,52],"mellitus.":[15,53],"Saroglitazar":[16,185,259,336,385],"(ZYH1)":[17],"novel":[20],"peroxisome":[21],"proliferator-activated":[22],"receptor":[23],"(PPAR)":[24],"agonist":[25],"predominant":[27],"PPAR\u03b1":[28],"and":[29,42,67,90,115,121,129,166,178,188,307,332,352,391],"moderate":[30,333],"PPAR\u03b3":[31],"activity.":[32],"It":[33],"has":[34,43],"been":[35],"developed":[36],"for":[37,279],"the":[38,64,125,132,138,155,176,195,204,221,235,241,264,274,280,298,369],"treatment":[39],"of":[40,56,69,103,127,134,149,175,209,254,271,276,312,358,377],"dyslipidaemia":[41],"favourable":[44],"effects":[45,126],"on":[46,131,273,297],"glycaemic":[47],"parameters":[48],"in":[49,71,86,93,118,154,163,181,194,246,287,290,305,334,344,361,394],"The":[54,224,238,250,355,375],"objective":[55],"this":[57,362,395],"phase":[58,83],"1":[59,135,212],"study":[60,85,177,363],"was":[61,77,91,186,256,260,268,284,302,364,386],"to":[62,203,231,315,388],"evaluate":[63],"pharmacokinetics,":[65],"safety":[66],"tolerability":[68],"saroglitazar":[70,104,255,313,359,378],"healthy":[72,87,119,160,168],"human":[73,88,139],"subjects.":[74],"METHODS:":[75],"This":[76],"randomized,":[79],"double-blind,":[80],"placebo-controlled,":[81],"single-centre,":[82],"I":[84,97,165,174],"volunteers,":[89],"performed":[92],"two":[94],"parts;":[95],"part":[96,122,164,173,182],"evaluated":[98,360],"single":[99],"ascending":[100],"oral":[101,310],"doses":[102,193,222,311,372],"(0.125,":[105],"0.25,":[106],"0.5,":[107],"1,":[108],"2,":[109],"4,":[110],"8,":[111],"16,":[112],"32,":[113],"64":[114],"128":[116,316,365],"mg)":[117],"subjects,":[120],"II":[123],"measured":[124],"food":[128],"sex":[130,272],"pharmacokinetics":[133,275,376],"mg":[136,317],"saroglitazar,":[137,277],"equivalent":[140],"efficacy":[141],"dose":[142,236,357],"derived":[143],"from":[144,172,229],"pre-clinical":[145],"studies.":[146],"A":[147],"total":[148],"96":[150],"subjects":[151,162,169],"were":[152,318,325,329],"enrolled":[153],"study,":[156,198],"which":[157,283],"included":[158],"88":[159],"male":[161],"16":[167],"(8":[170],"males":[171,306],"8":[179],"females)":[180],"II.":[183],"RESULTS:":[184],"rapidly":[187],"well":[189,319,392],"absorbed":[190],"across":[191,220,234],"all":[192],"single-dose":[196],"pharmacokinetic":[197],"median":[201],"time":[202],"peak":[205],"plasma":[206,226,242],"concentration":[207,227],"(t(max))":[208],"less":[210],"than":[211,289],"h":[213],"(range":[214],"0.63-1":[215],"h)":[216],"under":[217,240],"fasting":[218],"conditions":[219],"studied.":[223],"maximum":[225],"ranged":[228],"3.98":[230],"7,461":[232],"ng/mL":[233],"range.":[237],"area":[239],"concentration-time":[243],"curve":[244],"increased":[245],"dose-related":[248],"manner.":[249],"average":[251],"terminal":[252,281],"half-life":[253],"5.6":[257],"h.":[258],"not":[261,303,338],"eliminated":[262],"via":[263],"renal":[265],"route.":[266],"There":[267],"no":[269],"effect":[270,296],"except":[278],"half-life,":[282],"significantly":[285],"shorter":[286],"females":[288],"males.":[291],"Food":[292],"had":[293],"small":[295],"pharmacokinetics;":[299],"however,":[300],"it":[301],"consistent":[304],"females.":[308],"Single":[309],"up":[314],"tolerated.":[320],"No":[321],"serious":[322],"adverse":[323],"events":[324,328],"reported.":[326],"Adverse":[327],"generally":[330],"mild":[331],"nature.":[335],"did":[337],"show":[339],"any":[340],"clinically":[341],"relevant":[342],"findings":[343],"clinical":[345],"laboratory":[346],"investigations,":[347],"physical":[348],"examinations,":[349],"vital":[350],"signs":[351],"electrocardiograms.":[353],"CONCLUSION:":[354],"highest":[356],"mg,":[366],"several":[367],"times":[368],"estimated":[370],"therapeutic":[371],"(1-4":[373],"mg).":[374],"support":[379],"once":[381],"daily":[382],"dosage":[383],"schedule.":[384],"found":[387],"be":[389],"safe":[390],"tolerated":[393],"study.":[396]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}